Ko C W, Bhandari B, Yee J, Terhune W C, Maldonado R, Kasinath B S
Department of Medicine, University of Texas Health Science Center, San Antonio 78284, USA.
Mol Cell Biochem. 1996 Sep 6;162(1):65-73. doi: 10.1007/BF00250997.
Perlecan, the basement membrane heparan sulfate proteoglycan (HSPG), has been fully cloned from mouse and human tissues. When a cRNA probe of murine perlecan cDNA was employed in RNase protection assay to test whether rat glomerular epithelial cells (GEC) constitutively express perlecan, several bands of hybridization were seen, suggesting that sequences between rat and murine perlecan may not be identical. Using primers based on published cDNA sequences of murine and human perlecan and poly A+ RNA of rat GEC, we synthesized a 497 bp product (RPD-I) by RT-PCR. The deduced aminoacid sequence showed an 85% and 88% homology with domain I of murine and human perlecan, respectively. The three putative sites containing the consensus sequence SGD for attachment of heparan sulfate chains were fully conserved in the rat perlecan as was a site (NFT) for attachment of N-linked oligosaccharide. RPD-I detected a > 9.5 kb transcript of perlecan in RNA of GEC, similar in size to that present in rat glomeruli. Employing a riboprobe synthesized from RPD-I in RNase protection assay we examined whether dbcAMP regulated perlecan expression in the GEC. At 1, 6, 24 and 48 h of incubation, 1 mM dbcAMP caused 43%, 32%, 47% and 40% reduction in mRNA abundance of perlecan, respectively. Immunoprecipitation showed a corresponding reduction of 61%, 70% and 65% in the synthesis of 35SO4 labeled basement membrane HSPG by the GEC following 12, 24 and 48 h of incubation with dbcAMP. Following incubation for 1 and 24 h prostaglandins, PGE1 and PGE2 (1 uM), known activators of glomerular adenylate cyclase, reduced perlecan mRNA abundance to a similar extent as dbcAMP on northern analysis. Our results show that glomerular basement membrane HSPG synthesized by the GEC belongs to the perlecan family. Decrease of GEC perlecan gene expression and synthesis by cAMP and prostaglandins may be of relevance to proteinuric states characterized by activation of these mediators.
基底膜硫酸乙酰肝素蛋白聚糖(HSPG)核心蛋白聚糖已从小鼠和人类组织中完全克隆出来。当使用鼠核心蛋白聚糖cDNA的cRNA探针通过核糖核酸酶保护试验来检测大鼠肾小球上皮细胞(GEC)是否组成性表达核心蛋白聚糖时,观察到几条杂交带,这表明大鼠和小鼠核心蛋白聚糖之间的序列可能不相同。利用基于已发表的鼠和人核心蛋白聚糖cDNA序列以及大鼠GEC的聚腺苷酸加尾RNA的引物,我们通过逆转录聚合酶链反应(RT-PCR)合成了一个497 bp的产物(RPD-I)。推导的氨基酸序列与鼠和人核心蛋白聚糖的结构域I分别具有85%和88%的同源性。三个含有硫酸乙酰肝素链连接的共有序列SGD的推定位点在大鼠核心蛋白聚糖中完全保守,还有一个用于连接N-连接寡糖的位点(NFT)也是如此。RPD-I在GEC的RNA中检测到一条大于9.5 kb的核心蛋白聚糖转录本,其大小与大鼠肾小球中存在的转录本相似。在核糖核酸酶保护试验中使用从RPD-I合成的核糖探针,我们研究了二丁酰环磷腺苷(dbcAMP)是否调节GEC中核心蛋白聚糖的表达。在孵育1、6、24和48小时时,1 mM dbcAMP分别使核心蛋白聚糖的mRNA丰度降低了43%、32%、47%和40%。免疫沉淀显示,在与dbcAMP孵育12、24和48小时后,GEC合成的35S标记的基底膜HSPG相应减少了61%、70%和65%。在孵育1和24小时后,已知的肾小球腺苷酸环化酶激活剂前列腺素E1和E2(1 μM)在Northern分析中使核心蛋白聚糖mRNA丰度降低的程度与dbcAMP相似。我们的结果表明,GEC合成的肾小球基底膜HSPG属于核心蛋白聚糖家族。cAMP和前列腺素导致GEC核心蛋白聚糖基因表达和合成的减少可能与以这些介质激活为特征的蛋白尿状态有关。